FDA-NEUROLOGICAL › Clinical Considerations for Investigational Device Exemptions (IDEs) for Neurological Devices Targeting Disease Progression and Clinical Outcomes - Guidance for Industry and Food and Drug Administration Staff
Clinical Considerations for Investigational Device Exemptions (IDEs) for Neurological Devices Targeting Disease Progression and Clinical Outcomes - Guidance for Industry and Food and Drug Administration Staff
This document comes with our free Notification Service, good for the life of the document.
This document is available in either Paper or PDF format.
Document Number
1500021
Revision Level
2016 EDITION
Status
Current
Publication Date
Nov. 7, 2016
Page Count
11 pages